ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Leucovorin
Related studies linked through entity extraction aliases.
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Botensilimab and Balstilimab Optimization in Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- RECRUITING
- Phase
- PHASE2
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Status
- RECRUITING
- Phase
- PHASE3
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2